Home / Investors Information / EDAP to Showcase Ablatherm(R) HIFU Data at 4th International Symposium on Focal Therapy & Imaging in Prostate & Kidney Cancer Read more about EDAP to Showcase Ablatherm(R) HIFU Data at 4th International Symposium on Focal Therapy & Imaging in Prostate & Kidney Cancer EDAP Reports First Quarter 2011 Financial Results Read more about EDAP Reports First Quarter 2011 Financial Results Largest Long-Term Study Confirms EDAP's Ablatherm® HIFU is Effective, Highly Reproducible Primary Treatment for Localized Prostate Cancer Read more about Largest Long-Term Study Confirms EDAP's Ablatherm® HIFU is Effective, Highly Reproducible Primary Treatment for Localized Prostate Cancer EDAP Features New Ablatherm(R) HIFU Data Supporting Superior Efficacy for Treatment of Local Prostate Cancer at American Urological Association Annual Meeting Read more about EDAP Features New Ablatherm(R) HIFU Data Supporting Superior Efficacy for Treatment of Local Prostate Cancer at American Urological Association Annual Meeting EDAP Schedules Webcast and Conference Call of First Quarter 2011 Results Read more about EDAP Schedules Webcast and Conference Call of First Quarter 2011 Results Published 15-Year Clinical Review Supports EDAP's Ablatherm(R) HIFU as Viable Primary Treatment for Local Prostate Cancer at Any Stage Read more about Published 15-Year Clinical Review Supports EDAP's Ablatherm(R) HIFU as Viable Primary Treatment for Local Prostate Cancer at Any Stage EDAP Highlights Innovative Sonolith i-move Lithotripter at the Annual Japanese Urological Association Meeting Read more about EDAP Highlights Innovative Sonolith i-move Lithotripter at the Annual Japanese Urological Association Meeting EDAP and Collaboration Partners Awarded EUR 1.1 Million European Grant for HIFU Triggered Drug Delivery Program Read more about EDAP and Collaboration Partners Awarded EUR 1.1 Million European Grant for HIFU Triggered Drug Delivery Program EDAP Reports Fourth Quarter and Full Year 2010 Financial Results Read more about EDAP Reports Fourth Quarter and Full Year 2010 Financial Results EDAP to Exclusively Distribute Medical Measurement Systems Urodynamic Products in Japan Read more about EDAP to Exclusively Distribute Medical Measurement Systems Urodynamic Products in Japan Pagination First page « First Previous page ‹ Previous … Page 32 Page 33 Page 34 Page 35 Current page 36 Page 37 Page 38 Page 39 Page 40 … Next page Next › Last page Last » Subscribe to
EDAP to Showcase Ablatherm(R) HIFU Data at 4th International Symposium on Focal Therapy & Imaging in Prostate & Kidney Cancer Read more about EDAP to Showcase Ablatherm(R) HIFU Data at 4th International Symposium on Focal Therapy & Imaging in Prostate & Kidney Cancer
EDAP Reports First Quarter 2011 Financial Results Read more about EDAP Reports First Quarter 2011 Financial Results
Largest Long-Term Study Confirms EDAP's Ablatherm® HIFU is Effective, Highly Reproducible Primary Treatment for Localized Prostate Cancer Read more about Largest Long-Term Study Confirms EDAP's Ablatherm® HIFU is Effective, Highly Reproducible Primary Treatment for Localized Prostate Cancer
EDAP Features New Ablatherm(R) HIFU Data Supporting Superior Efficacy for Treatment of Local Prostate Cancer at American Urological Association Annual Meeting Read more about EDAP Features New Ablatherm(R) HIFU Data Supporting Superior Efficacy for Treatment of Local Prostate Cancer at American Urological Association Annual Meeting
EDAP Schedules Webcast and Conference Call of First Quarter 2011 Results Read more about EDAP Schedules Webcast and Conference Call of First Quarter 2011 Results
Published 15-Year Clinical Review Supports EDAP's Ablatherm(R) HIFU as Viable Primary Treatment for Local Prostate Cancer at Any Stage Read more about Published 15-Year Clinical Review Supports EDAP's Ablatherm(R) HIFU as Viable Primary Treatment for Local Prostate Cancer at Any Stage
EDAP Highlights Innovative Sonolith i-move Lithotripter at the Annual Japanese Urological Association Meeting Read more about EDAP Highlights Innovative Sonolith i-move Lithotripter at the Annual Japanese Urological Association Meeting
EDAP and Collaboration Partners Awarded EUR 1.1 Million European Grant for HIFU Triggered Drug Delivery Program Read more about EDAP and Collaboration Partners Awarded EUR 1.1 Million European Grant for HIFU Triggered Drug Delivery Program
EDAP Reports Fourth Quarter and Full Year 2010 Financial Results Read more about EDAP Reports Fourth Quarter and Full Year 2010 Financial Results
EDAP to Exclusively Distribute Medical Measurement Systems Urodynamic Products in Japan Read more about EDAP to Exclusively Distribute Medical Measurement Systems Urodynamic Products in Japan
